Molinuevo JL, Ayton S, Batrla R et al (2018) Current state of Alzheimer’s fluid biomarkers. Acta Neuropathol 136(6):821–853. https://doi.org/10.1007/s00401-018-1932-x
Article CAS PubMed PubMed Central Google Scholar
Scheltens P, De Strooper B, Kivipelto M et al (2021) Alzheimer’s disease. Lancet (London, England) 397(10284):1577–1590. https://doi.org/10.1016/S0140-6736(20)32205-4
Millan MJ (2017) Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer’s disease: an integrative review. Prog Neurobiol. https://doi.org/10.1016/j.pneurobio.2017.03.004
Bishop NA, Lu T, Yankner BA (2010) Neural mechanisms of ageing and cognitive decline. Nature 464(7288):529–535. https://doi.org/10.1038/nature08983
Article CAS PubMed PubMed Central Google Scholar
Fang EF, Hou Y, Palikaras K et al (2019) Mitophagy inhibits amyloid-beta and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease. Nat Neurosci 22(3):401–412. https://doi.org/10.1038/s41593-018-0332-9
Article CAS PubMed PubMed Central Google Scholar
Lautrup S, Sinclair DA, Mattson MP et al (2019) NAD in brain aging and neurodegenerative disorders. Cell Metab 30(4):630–655. https://doi.org/10.1016/j.cmet.2019.09.001
Article CAS PubMed PubMed Central Google Scholar
Peña-Bautista C, Baquero M, Vento M et al (2019) Omics-based biomarkers for the early Alzheimer disease diagnosis and reliable therapeutic targets development. Curr Neuropharmacol 17(7):630–647. https://doi.org/10.2174/1570159X16666180926123722
Article PubMed PubMed Central Google Scholar
Hampel H, Nisticò R, Seyfried NT et al (2021) Omics sciences for systems biology in Alzheimer’s disease: state-of-the-art of the evidence. Ageing Res Rev. https://doi.org/10.1016/j.arr.2021.101346
Pimenova AA, Raj T, Goate AM (2018) Untangling genetic risk for Alzheimer’s disease. Biol Psychiat 83(4):300–310. https://doi.org/10.1016/j.biopsych.2017.05.014
Article CAS PubMed Google Scholar
Mostafavi S, Gaiteri C, Sullivan SE et al (2018) A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer’s disease. Nat Neurosci 21(6):811–819. https://doi.org/10.1038/s41593-018-0154-9
Article CAS PubMed PubMed Central Google Scholar
Wesseling H, Mair W, Kumar M et al (2020) Tau PTM profiles identify patient heterogeneity and stages of Alzheimer’s disease. Cell. https://doi.org/10.1016/j.cell.2020.10.029
Article PubMed PubMed Central Google Scholar
Mahajan UV, Varma VR, Griswold ME et al (2020) Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: a targeted metabolomic and transcriptomic study. PLoS Med 17(1):e1003012. https://doi.org/10.1371/journal.pmed.1003012
Article CAS PubMed PubMed Central Google Scholar
Márquez F, Yassa MA (2019) Neuroimaging biomarkers for Alzheimer’s disease. Mol Neurodegener 14(1):21. https://doi.org/10.1186/s13024-019-0325-5
Article PubMed PubMed Central Google Scholar
Zetterberg H, Burnham SC (2019) Blood-based molecular biomarkers for Alzheimer’s disease. Mol Brain 12(1):26. https://doi.org/10.1186/s13041-019-0448-1
Article CAS PubMed PubMed Central Google Scholar
Schonhaut DR, McMillan CT, Spina S et al (2017) F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: a multicenter study. Ann Neurol 82(4):622–634. https://doi.org/10.1002/ana.25060
Article CAS PubMed PubMed Central Google Scholar
Mapstone M, Cheema AK, Fiandaca MS et al (2014) Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med 20(4):415–418. https://doi.org/10.1038/nm.3466
Article CAS PubMed PubMed Central Google Scholar
Wang M, Beckmann ND, Roussos P et al (2018) The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer’s disease. Sci Data. https://doi.org/10.1038/sdata.2018.185
Article PubMed PubMed Central Google Scholar
Serrano-Pozo A, Das S, Hyman BT (2021) APOE and Alzheimer’s disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol 20(1):68–80. https://doi.org/10.1016/S1474-4422(20)30412-9
Article CAS PubMed PubMed Central Google Scholar
de Rojas I, Moreno-Grau S, Tesi N et al (2021) Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores. Nat Commun 12(1):3417. https://doi.org/10.1038/s41467-021-22491-8
Article CAS PubMed PubMed Central Google Scholar
Cuperlovic-Culf M, Badhwar A (2020) Recent advances from metabolomics and lipidomics application in Alzheimer’s disease inspiring drug discovery. Expert Opin Drug Discov 15(3):319–331. https://doi.org/10.1080/17460441.2020.1674808
Article CAS PubMed Google Scholar
Kunkle BW, Grenier-Boley B, Sims R et al (2019) Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nat Genet 51(3):414–430. https://doi.org/10.1038/s41588-019-0358-2
Article CAS PubMed PubMed Central Google Scholar
Jansen IE, Savage JE, Watanabe K et al (2020) Author Correction: Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk. Nat Genet 52(3):354. https://doi.org/10.1038/s41588-019-0573-x
Article CAS PubMed Google Scholar
Bertram L, Tanzi RE (2019) Alzheimer disease risk genes: 29 and counting. Nat Rev Neurol 15(4):191–192. https://doi.org/10.1038/s41582-019-0158-4
Dourlen P, Kilinc D, Malmanche N et al (2019) The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis? Acta Neuropathol 138(2):221–236. https://doi.org/10.1007/s00401-019-02004-0
Article CAS PubMed PubMed Central Google Scholar
Ma Y, Jun GR, Zhang X et al (2019) Analysis of whole-exome sequencing data for Alzheimer disease stratified by APOE genotype. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2019.1456
Article PubMed PubMed Central Google Scholar
Schwartzentruber J, Cooper S, Liu JZ et al (2021) Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer’s disease risk genes. Nat Genet 53(3):392–402. https://doi.org/10.1038/s41588-020-00776-w
Article CAS PubMed PubMed Central Google Scholar
Wightman DP, Jansen IE, Savage JE et al (2021) A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease. Nat Genet 53(9):1276–1282. https://doi.org/10.1038/s41588-021-00921-z
Article CAS PubMed Google Scholar
Kunkle BW, Grenier-Boley B, Sims R et al (2019) Author Correction: genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat Genet 51(9):1423–1424. https://doi.org/10.1038/s41588-019-0495-7
Article CAS PubMed PubMed Central Google Scholar
Gaiteri C, Mostafavi S, Honey CJ et al (2016) Genetic variants in Alzheimer disease - molecular and brain network approaches. Nat Rev Neurol 12(7):413–427. https://doi.org/10.1038/nrneurol.2016.84
Article CAS PubMed PubMed Central Google Scholar
Kleineidam L, Chouraki V, Próchnicki T et al (2020) PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment. Acta Neuropathol 139(6):1025–1044. https://doi.org/10.1007/s00401-020-02138-6
Article PubMed PubMed Central Google Scholar
Cuddy LK, Prokopenko D, Cunningham EP et al (2020) Aβ-accelerated neurodegeneration caused by Alzheimer’s-associated variant R1279Q is rescued by angiotensin system inhibition in mice. Sci Transl Med. https://doi.org/10.1126/scitranslmed.aaz2541
Prokopenko D, Lee S, Hecker J et al (2022) Region-based analysis of rare genomic variants in whole-genome sequencing datasets reveal two novel Alzheimer’s disease-associated genes: DTNB and DLG2. Mol Psychiatry. https://doi.org/10.1038/s41380-022-01475-0
Article PubMed PubMed Central Google Scholar
Neumann A, Kucukali F, Bos I et al (2022) Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer’s disease CSF profile of neuronal injury and inflammation. Mol Psychiatry. https://doi.org/10.1038/s41380-022-01437-6
Article PubMed PubMed Central Google Scholar
Ming C, Wang M, Wang Q et al (2021) Whole genome sequencing-based copy number variations reveal novel pathways and targets in Alzheimer’s disease. Alzheimers Dement. https://doi.org/10.1002/alz.12507
留言 (0)